Search
Janos Csongor Kerekes/Getty Images
Medicine

New Malaria Vaccine Gets First Large-Scale Human Trial in Africa

RTS,S, also known as Mosquirix, was developed by GlaxoSmithKline, and the large-scale three-country pilot will test it on children aged five to 17 months.

April 24, 2017
9:06 AM EDT